Figure S1 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

<p>Supplementary Figure 1</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Renee Maria Saliby (16426550) (author)
Beste egile batzuk:	Talal El Zarif (14959088) (author), Ziad Bakouny (15015803) (author), Valisha Shah (16426553) (author), Wanling Xie (15062851) (author), Ronan Flippot (16426556) (author), Thomas Denize (15028293) (author), M. Harry Kane (16426559) (author), Katrine N. Madsen (16426562) (author), Miriam Ficial (15015800) (author), Laure Hirsch (16426565) (author), Xiao X. Wei (15032322) (author), John A. Steinharter (16426568) (author), Lauren C. Harshman (16426571) (author), Ulka N. Vaishampayan (15051039) (author), Mariano Severgnini (16426574) (author), David F. McDermott (16426577) (author), Gwo-Shu Mary Lee (15045378) (author), Wenxin Xu (15015872) (author), Eliezer M. Van Allen (15054227) (author), Bradley A. McGregor (15037805) (author), Sabina Signoretti (14954811) (author), Toni K. Choueiri (15043079) (author), Rana R. McKay (15062884) (author), David A. Braun (15043076) (author)
Argitaratua:	2025
Gaiak:	Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Biomarkers Serum biomarkers Genitourinary Cancers Renal cancer Immunotherapy Checkpoint blockade Precision Medicine Translational Research Tumor Microenvironment Immune cells and the microenvironment
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak